2018 | Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer. | GYNECOLOGIC ONCOLOGY |
2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | GYNECOLOGIC ONCOLOGY |
2021 | Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee | GYNECOLOGIC ONCOLOGY |
2022 | Long term oncologic and reproductive outcomes after robot-assisted radical trachelectomy for early-stage cervical cancer. An international multicenter study
| GYNECOLOGIC ONCOLOGY |
2021 | Markedly increased risk of malignancies in women with endometriosis | GYNECOLOGIC ONCOLOGY |
2004 | Minimal change disease in a patient with ovarian papillary serous carcinoma | GYNECOLOGIC ONCOLOGY |
2003 | Osteopontin is down-regulated in hydatidiform mole | GYNECOLOGIC ONCOLOGY |
2019 | Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
| GYNECOLOGIC ONCOLOGY |
2003 | Pelvic leiomyomatosis with intracaval and intracardiac extension: a case report and review of the literature | GYNECOLOGIC ONCOLOGY |
2018 | Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer | GYNECOLOGIC ONCOLOGY |
2011 | Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression. | GYNECOLOGIC ONCOLOGY |
2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | GYNECOLOGIC ONCOLOGY |
2022 | Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea | GYNECOLOGIC ONCOLOGY |
2008 | Robotic radical hysterectomy with pelvic lymphadenectomy for cervical carcinoma: a pilot study | GYNECOLOGIC ONCOLOGY |
2022 | Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study | GYNECOLOGIC ONCOLOGY |
2007 | The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance | GYNECOLOGIC ONCOLOGY |
2011 | The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer | GYNECOLOGIC ONCOLOGY |
2005 | The influence of time intervals between loop electrosurgical excision and subsequent hysterectomy on the morbidity of patients with cervical neoplasia | GYNECOLOGIC ONCOLOGY |
2021 | The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis | GYNECOLOGIC ONCOLOGY |
2016 | Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapy | GYNECOLOGIC ONCOLOGY |
2016 | Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectives. | GYNECOLOGIC ONCOLOGY |
2021 | Ultrasonographic evaluation of ovarian mass for predicting malignancy in pregnant women | GYNECOLOGIC ONCOLOGY |
1998 | Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma | GYNECOLOGIC ONCOLOGY |
2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |